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ABSTRACT
Introduction
 A number of investigators have shown that endothelial dysfunction in liver cirrhosis can be indicated by
increased levels of nitric oxide (NO) and von Willebrand factor (vWF). The cause of this increase is still
unclear. It is believe to be correlated with hyperdinamic circulation and endotoxemia, which are common in
liver cirrhosis.
The Aim of This Study
To compare the levels of NO and vWF in liver cirrhosis patients with those in healthy control subjects, and
to investigate whether there is a correlation between levels of NO and vWF with the severity of the disease
according to the Child Pugh Criteria
Material and Method
This study was conducted from February until June 2001 in 35 liver cirrhosis patients at Dr. Pirngadi and H.
Adam Malik Hospital and some private hospitals in Medan. The mean age of patients with liver cirrhosis was 54
+ 12.26 years, the youngest being 31 years and the oldest 75 years, and 20 healthy controls while the mean age
of the control subject was 55.20 + 13.04 years, the youngest being 31 years and the oldest 76 years. Based on
Child Pugh criteria, 9 were classified as Child Pugh class A, 13 in class B, 13 in class C. The criteria for liver
cirrhosis were based on clinical examination, laboratory findings and liver ultrasound examination. Cirrhotic
patients with hypercolestrolemia, hypertension, heart failure, myocardial infraction, renal failure diabetes, COPD
were those on drugs, such as antibiotics and branchodilators were excluded from the study.
Result
The mean level of NO in patients with liver cirrhosis was 6.2600 + 4.4456 µM, while the mean NO level in
control subjects was 3.2325 + 3.2355 µM, p<0.05. The mean level of NO in Child Pugh class A patients was
6.6889 + 3.9757µM, compared to control p<0.05; in Child Pugh class B the mean level was 4.8308 + 2.4642
µM compared to control p>0.05. There was a significant increase in the level of NO associated with the
severity of liver cirrhosis. The mean level of vWF in patients with liver cirrhosis was 399.514  +  175.313%
while the mean vWF level in control subjects was 139.100  +  51.144%, p<0.05. The mean level of vWF in
Child Pugh class A patients was 231.778  +  43.8576%, compared to control p<0.05; in Child Pugh class B
was 365.846  +  110.034%, compared to control p<0.05, in Child Pugh class C was 549.308 +  164.483%,
compared to control p<0.05. There was significant increase in the level of vWF correlated with severity of
liver cirrhosis.
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INTRODUCTION
Liver cirrhosis is still the most frequent liver disease
found in various hospitals in Indonesia.1,2 In Southeast
Asia, the most common cause of liver cirrhosis is
Hepatitis virus B and C.3 Liver cirrhosis is the final stage
of a chronic liver disease resulting from an acute
process that may not clinically present any significant
physical abnormality up to the point of severe clinical
condition.
Endothelial dysfunction is defined as imbalance
between relaxation factors, and contraction pro-
coagulant and anti-coagulant mediators or substances
that inhibit or accelerate growth. Biochemical markers
that are commonly used to determine endothelial
dysfunction as well as improved endothelial function
include NO, Endothelin-1, von Willebrand factor (vWF),
Thrombomodulin, E-Selectin, sVCAM-1, sICAM-1,
PAI-1, Microalbuminuria, and F2 isoproston.4,5
Several clinical and experimental studies found
endothelial dysfunction in liver cirrhosis demonstrated
through increased levels of nitric oxide and von Willebrand
factor. The cause of such increased levels is still unclear,
possibly related to hyperdynamic circulation and
endotoxemia commonly encountered in liver cirrhosis.
Vallance and Moncada stated that increased
synthesis and release of nitric oxide is caused by
endotoxin and/or cytokine may be responsible for
arteriolar vasodilatation and related to ascites in
cirrhosis.6 Guarner et al also found a correlation between
endotoxin in cirrhosis and nitric and nitrate levels, which
are the final products of nitric oxide metabolism.7 Even
though the role of  endotoxin and/or cytokine is still    under
debate, further study support the role of NO as the chief
vasodilator responsible for the development of a
hyperdynamic circulation in cirrhosis.8
Von Willebrand factor is a multimer glycoprotein
synthesized by vascular endothelial cells and
megakaryocytes, secreted and stored in intraendothelial
Weibel Pallade bodies and platelet alpha-granules.9 Plasma
von Willebrand factors are increased in various conditions
during endothelial dysfunction. The cause of such increase
in von Willebrand factor is unknown, possibly due to
endothelial activation by cytokines and/or endothelial
damage.8,10
Ferro et al found increased von Willebrand factor due
to endotoxemia in liver cirrhosis and such increase is
correlated with the degree of liver failure based on Child-
Pugh criteria.11 Albornoz et al also found a correlation
between increased levels of von Willebrand factor and
NO levels in patients with cirrhosis, where an increase
in these two endothelial factors are also correlated with
the severity of the disease.
In the last few years, there has been additional proof
that mechanical stimulation can directly influence
endothelial structure and function. It has been shown
that sheer stress can increase endothelial NOS and NO
production. Thus, high levels of endothelial stress in liver
cirrhosis caused by hemodynamic changes may be
involved in causing excessive production of NO. On the
other hand, local endothelial damage may cause a
disturbance in Weibel Pallade bodies and endothelial
membranes, thus releasing or causing leakage of von
Willebrand factor (vWf).8,10,11
From the account above, a study was conducted to
determine whether there is a difference in the levels of
NO and von Willebrand factor in patients with liver
cirrhosis and normal subjects, and if the levels of the
two endothelial factors were in accordance with the
severity of disease according to the Child Pugh criteria.
AIM OF STUDY
• To determine whether there is an increase in the
levels of NO and von Willebrand factor in patients
with liver cirrhosis compared to healthy subjects
• To determine whether the levels of NO and von
Willebrand factor in patients with liver cirrhosis is in
line with the severity of illness according to the Child
Pugh criteria
• To determine whether there is a correlation between
the levels of NO and von Willebrand factor in
patients with liver cirrhosis
Conclusion
The level of NO was significant higher in liver cirrhosis patients compared to control subjects, but there
was no correlation between the increase in the level of NO with the severity of the disease. The levels of vWF
was significantly higher in liver cirrhosis patients compared to control, and there was a correlation between
increased levels of vWF and the severity of the disease.
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Volume 3, Number 3, December 2002 71
Nitric Oxide and Von Willebrand Factor Levels as Markers of Endothelial Dysfunction in Liver Cirrhosis
MATERIALS AND METHOD
This descriptive analytic study was conducted from
February 2001 to July 2001 at Dr. Pringadi General
Hospital and Adam Malik General Public Hospital,
Medan.
Subjects consisted of ambulatory and in-patients with
liver cirrhosis. Subjects underwent routine laboratory
evaluation, liver function test, SPE, prothrombine time,
and liver ultrasound.
Control subjects consisted of healthy subjects (with
normal findings on physical and laboratory evaluation).
Case and control subjects consented to participate in the
studies. Case and control subjects underwent evaluation
for nitric/nitrate acid with enzymatic method using Griess
diazotasion reaction, while von Willebrand factor levels
were determined using Elisa method. Nitric/nitrate
levels were stated in umol/L, while von Willebrand    factor
antigen stated in %.
Case subjects were chosen according to the
following criteria for inclusion: patients with liver
cirrhosis based on clinical, laboratory, and ultrasound
evaluation.
Criteria for exclusion: patients with liver cirrhosis and
control subjects suffering from hypercholesterolemia,
hypertension, heart failure, myocardial infarction, renal
failure, diabetes, chronic pulmonary obstruction disease,
malignancy, pregnancy, less than 2 weeks following
surgery, following heavy and moderate exercise, use of
antibiotics that are not absorbed in the bowel or current
use of vasodilators.
DATA ANALYSIS
• Independent t-test to compare the mean value of
NO and von Willebrand factor between case and
control groups.
• Spearman or Pearson correlation to see the
correlation between NO and von Willebrand factor
in patients with liver cirrhosis.
RESULTS
Out of 35 patients with liver cirrhosis included in this
study, 27 were male and 8 were female, with an
average age of 54 ± 12.26 years, with the youngest
being 31 years and the oldest 75 years. While in control
subjects, 20 are healthy subjects with an average age of
55.20 ± 13.04 years, the youngest being 31 years of age,
and the oldest being 76 years. There is no significant
difference in the age of case and control subjects.
Out of the 35 patients with cirrhosis, 22 of them scored
less than 9 in the Child Pugh classification, and 13
patients had a score of over 9; 23 patients suffered from
ascites and 12 did not.
The results of nitric oxide and von Willebrand factor
evaluation in patients with cirrhosis and control subjects
can be found in the following tables.
Table 1. Comparison of NO Levels Between Cirrhotic and Control Patients 
Variable Subject Group N X SD p 
Liver cirrhosis 35 6.2600 4.4456 NO level 
Control  20 3.2325 3.2355 
0.010 
NO: Nitric oxide 
Table 2. Comparison of NO Levels Between Patients with Child Pugh <9 and Control  
Variable Subject Group N X SD p 
Child Pugh <9 22 5.5909 3.2196 NO level 
Control  20 3.2325 3.2355 
0.023 
NO: Nitric oxide 
The mean NO level in patients with liver cirrhosis was significantly higher than in control subjects (p <0.05)
Table 3. Comparison of NO Levels Between Patients with Child Pugh >9 and Control 
Variable Subject Group N X SD p 
Child Pugh >9 13 7.3923 5.9705 NO level 
Control  20 3.2325 3.2355 
0.014 
NO: Nitric oxide 
The mean NO level in patients with liver cirrhosis with a Child Pugh score of less than 9 was significantly higher than
in control subjects (p <0.05)
The mean NO level in patients with liver cirrhosis with a Child Pugh score of more than 9 was significantly higher
than in control subjects (p <0.05)
RESULT OF NO EVALUATION
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The mean NO level in patients with liver cirrhosis with a Child Pugh score of less than 9 was not significantly higher than 
in case subjects with a Child Pugh score of more than 9 (p >0.05)  
Table 5. Comparison of NO Levels Between Cirrhotic Patients with and without Ascites  
Variable Subject Group N X SD p 
NO level Ascites 23 6.4652 5.0983 0.711 
No ascites 12 5.8667 2.9742 
NO: Nitric oxide  
The mean NO level in liver cirrhosis patients with ascites was higher than in liver cirrhosis patients without ascites, but 
the difference was not statistically significant (p>0.05)  
 
Table 6. Comparison of vWf Levels Between Cirrhotic and Control Patients  
Variable Subject Group N X SD p 
vWf level Liver cirrhosis 35 399.514 175.313 0.0000 
Control 20 139.100 51.144 
The mean vWf level in patients with liver cirrhosis was significantly higher than in control subjects (p<0.05)  
 
 
 
 
 
The mean vWf level in patients with liver cirrhosis with a Child Pugh score of less than 9 was significantly higher 
than in control subjects (p<0.05)  
 
Table 8. Comparison of vWf Levels Between Patients with Child Pugh >9 and Control  
Variable Subject Group N X SD p 
vWf level Child Pugh >9 13 549.308 164.483 0.0000 
Control 20 139.100 51.144 
The mean vWf level in patients with liver cirrhosis with a Child Pugh score of more than 9 was significantly higher 
than in control subjects (p<0.05) 
 
Table 9. Comparison of vWf Levels Between Patients with Child Pugh <9 and >9 
Variable Subject Group N X SD p 
vWf level Child Pugh <9 22 311.000 110.468 0.0000 
Child Pugh >9 13 549.308 164.483 
The mean vWf level in patients with liver cirrhosis with a Child Pugh score of less than 9 was significantly higher 
than in case subjects with a Child Pugh score of more than 9 (p<0.05)  
 
 
 
 
 
The mean vWf level in liver cirrhosis patients with ascites was significantly higher than in liver cirrhosis patients 
without ascites (p<0.05)  
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Table 4. Comparison of NO Levels Between Patients with Child Pugh <9 and >9 
Variable Subject Group N X SD p 
Child Pugh <9 22 5.5909 3.2196 NO level 
Child Pugh >9 13 7.3923 5.9705 
0.253 
NO: Nitric oxide 
Table 7. Comparison of vWf Levels Between Patients with Child Pugh <9 and Control  
Variable Subject Group N X SD p 
Child Pugh <9 22 311.000 110.468 vWf level 
Control  20 139.100 51.144 
0.0000 
 
Table 10. Comparison of vWf Levels Between Cirrhotic Patients with and without Ascites 
Variable Subject Group N X SD p 
Ascites 23 455.087 176.076 vWf level 
No ascites  12 293.000 118.991 
0.007 
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CORRELATION BETWEEN NO AND VWF LEVELS IN
LIVER CIRRHOSIS
No linear correlation was found between NO and
fvW levels of liver cirrhosis, with a Pearson correlation
test of r = - 0.053 and p>0.05.
DISCUSSION
NO levels in Liver Cirrhosis
Several clinical studies have found increased NO
levels in liver cirrhosis. Vallance and Moncada stated
that endotoxemia and/or cytokine related with cirrhosis
can induce excessive NO production through the
synthesis of iNOS, and is responsible for increased NO
in cirrhosis.6 Guarner et al found increased NO levels in
patients with liver cirrhosis, and the increase is higher in
patients with ascites. Increased NO levels is also
correlated with the level of endotoxemia.7 Barak et all
found a higher Nitric/Nitrate level in patients with
cirrhosis compared to in control subjects.12 Campllo found
higher NO levels in patients with severe ascites
compared to healthy subjects, while patients with mild
ascites or no ascites demonstrate normal NO levels.
Albomoz et al found higher levels of NO in patients with
cirrhosis compared to control subjects, and the increase
in NO is in line with the severity of disease, with a higher
level of NO in cirrhotic patients with a Child Pugh score
of over 9, compared to cirrhotic patients with a Child
Pugh score of less than 9.8
In this study, we found a mean NO level of 6.2600 ±
4.4456 mmol/l, while the mean NO level in control
subjects was 3.2325 ± 3.2325 mmol/l, demonstrating a
statistically significant difference with a p of less than
0.05 (Table 1). Such result is the same as that found by
several previous researchers.
The cause for increased NO levels in cirrhosis is still
unclear. It is suspected to be related to a hyperdinamic
condition and the presence of chronic endotoxemia in
liver cirrhosis. Such hyperdynamic circulation causes high
shear stress, which can directly affect endothelial
structure and function. Shear stress increases eNOS
enzyme activity, which then further increases NO
production. In addition, general endotoxemia found in
cirrhosis can induce excessive production of NO through
the synthesis of iNOS enzyme. Aside from shear stress
and endotoxemia, cathecolamine, estrogen, and P
substance, which are all increased in cirrhosis, increase
iNOS enzyme synthesis.14,15,16,17
From this study, patients with cirrhosis were
classified into two groups compared to liver function
reserve (Child Pugh classification, with a score of less
than 9 and over 9). There is a significant difference in
the mean NO level in subjects with a Child Pugh score
of less than 9 is 5.5909 ± 3.2196 mmol/l, compared to
that of control subjects (3.2325 ± 3.2325 mmol/l), with a
p of less than 0.05 (Table 2). However, there was no
significant difference in the mean NO level in patients
with a Child Pugh score of less than 9 compared with
those with a Child Pugh score of over 9 (7.3923  ± 5.9705
mmol/l), p >0.05 (Table 4).
From the data above, we can see that patients with
cirrhosis are found with higher NO levels compared to
those in control subjects. However, the increase is not in
line with the severity of disease according to the Child
Pugh criteria. Such results were different from that
found by a previous researcher, which found increased
NO levels in line with the severity of liver cirrhosis.
Various factors might have caused such difference, such
as long-standing cirrhosis, which could cause
a chronically hyperdynamic condition, or the patient might
have received antibiotics or nitrate drugs that were not
discovered during history-taking. Antibiotics, particularly
those that are not absorbed in the bowel, reduces the
level of endotoxin, which thus reduces the synthesis of
iNOS enzyme.7,8 While nitrate drugs act by releasing
NO from its molecule, thus increasing the level of NO in
the blood.18 To avoid such problem, administration of all
drugs should be terminated several days to weeks prior
to taking blood samples, to ensure that the patient is
completely free from the influence of drugs. In this study,
drug administration was not terminated. Albornoz et al,
in a study on 27 patients with liver cirrhosis, found a
higher NO level in patients with ascites compared to
those without.
In this study, out of 35 patients with liver cirrhosis, 23
patients suffered from ascites, while 12 patients did not.
The mean NO level of patients with ascites was 6.4652
± 5.0983 mmol/l, while the mean NO level in patients
without ascites was 5.8667 ± 2.9742 mmol/l.
The mean NO level in patients with ascites was still
relatively higher than in those without ascites, but the
difference was not statistically significant (Table 5). From
the data above, we can see that ascites does not
influence the level of NO in liver cirrhosis. This differs
from what was found by the two previous researchers
mentioned above. The difference might be caused by
the difference in the severity and duration of ascites.
Von Willebrand Factor Levels in Liver Cirrhosis
Several clinical studies found a higher elvel of von
Willebrand factor in patients with liver cirrhosis. The
cause of such increase is still unclear. It may be due to
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cytokine activation or endothelial damage, or perhaps
high levels of von Willebrand factors may be associated
with a compensation mechanism for hemostatic
disturbance in chronic liver disease. Local endothelial
damage may cause a disturbance in Weibel Pallade
Bodies, thus releasing or causing leackage of von
Willebrand factors.8,11 Ferro et al found a progressive
increase of von Willebrand factor and endotoxemia in
accordance with the severity of disease according to
Child Pugh criteria.11 Beer et al found a von Willebrand
factor of over 400 % normal levels. Albornoz et al found
a higher level of von Willebrand factor in cirrhotic
patients compared with normal subjects, and the increase
was in line with the severity of disease according to the
Child-Pugh criteria. In this study, we found an average
von Willebrand factor level of 399 ± 175.313 % in
patients with liver cirrhosis and a von Willebrand factor
level of 139 ± 51.144 % in control subjects. This
difference was statistically significant (p<0.05) (Table
6). The average level of von Willebrand factor in liver
cirrhosis scoring less than 9 in the Child Pugh
classification was 311.000 ± 110.468 %, which was
significantly higher than control according to statistics
(p<0.05) (Table 7). The average level of von Willebrand
factor in cirrhotic patients with a Child Pugh
classification of over 9 is 549.308 ± 164.483 %, which
was significantly higher than control according to
statistics (p<0.05) (Table 8). The average von Willebrand
factor level in patients with liver cirrhosis scoring less
than 9 in the Child Pugh classification was 311.000 ±
110.468 %, which was, by statistics, significantly higher
than the level in patients scoring over 9 (Table 9). The
results of this study were in line with those found by the
previous researcher. From the data above, we could see
an average increase in the level of von Willebrand
factor in patients with liver cirrhosis, and that the in-
crease was in line with the severity of disease according
to the Child Pugh classification. In his study, Albornoz et
al found a higher von Willebrand factor level in cirrhotic
patients with ascites compared to those without, but the
exact mechanism causing this condition is still unclear.8
In this study, out of the 35 patients with cirrhosis,
there were 23 patients with ascites and 12 without
ascites. The average von Willebrand factor level in those
with ascites was 455.087 ± 176.076%, while the
average von Willebrand factor level in those without
ascites was 293.000 ± 118.991. The average von
Willebrand factor level in ascites was higher than in those
without ascites, which demonstrated a statistically
significant difference (Table 10). From this data, we can
see that the presence of ascites can influence the
increase in von Willebrand factor in patients with liver
cirrhosis, which was in accordance to the findings of
previous researchers. In his study, Albornoz also found
a linear correlation between NO levels and von Willebrand
factor levels in patients with liver cirrhosis.8
In this study, we found a higher average level of NO
and von Willebrand factor in patients with cirrhosis
compared to healthy subjects, which after analysis with
Pearson correlation resulted in an r value of -0.053 and
a p of over 0.05. This means that there was no linear
correlation between NO levels and von Willebrand
factor levels in patients with liver cirrhosis. This finding
was unlike those of previous researchers, possibly due
to long-standing cirrhosis, the influence of drugs such as
antibiotics, vasodilators (which the patients had
previously received, but was not found during history-
taking, since the patients themselves often do not know
what drugs they have consumed), which might have
influenced the levels of one of the endothelial factors.
CONCLUSION
1. There is an increase in the levels of NO and von
Willebrand factor in patients with liver cirrhosis
compared to healthy subjects.
2. The increase in NO in liver cirrhosis was in line with
the severity of disease, while the increase in von
Willebrand factor level was in line with the severity
of disease according to the Child Pugh criteria.
Ascites does not have an influence on the level of
NO in patients with liver cirrhosis, but influences the
level of von Willebrand factor. There was no linear
correlation between the levels of NO and von
Willebrand factor in liver cirrhosis.
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